Page last updated: 2024-10-25

dantrolene and Degenerative Diseases, Central Nervous System

dantrolene has been researched along with Degenerative Diseases, Central Nervous System in 2 studies

Dantrolene: Skeletal muscle relaxant that acts by interfering with excitation-contraction coupling in the muscle fiber. It is used in spasticity and other neuromuscular abnormalities. Although the mechanism of action is probably not central, dantrolene is usually grouped with the central muscle relaxants.
dantrolene : The hydrazone resulting from the formal condensation of 5-(4-nitrophenyl)furfural with 1-aminohydantoin. A ryanodine receptor antagonist used for the relief of chronic severe spasticity and malignant hyperthermia.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Sun, L1
Wei, H1
Drake, TM1

Reviews

1 review available for dantrolene and Degenerative Diseases, Central Nervous System

ArticleYear
Ryanodine Receptors: A Potential Treatment Target in Various Neurodegenerative Disease.
    Cellular and molecular neurobiology, 2021, Volume: 41, Issue:8

    Topics: Animals; Brain; Calcium Channel Blockers; Calcium Signaling; Dantrolene; Humans; Neurodegenerative D

2021

Other Studies

1 other study available for dantrolene and Degenerative Diseases, Central Nervous System

ArticleYear
Unfolding the promise of translational targeting in neurodegenerative disease.
    Neuromolecular medicine, 2015, Volume: 17, Issue:2

    Topics: Activating Transcription Factor 6; Aging; Animals; Apoptosis; Cellular Microenvironment; Dantrolene;

2015